Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Regarding the PTSC Annual SHM held on 1/28/2010

I wasn't aware of that. I thought that if a company had a surplus of money say $100,000,000 and wanted to pay out $50,000,000 in dividends to the shareholdres that would not effect the s/p at all.

Share
New Message
Please login to post a reply